Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Mupirocin
Drug ID BADD_D01504
Description Mupirocin, formerly termed pseudomonic acid A,[A178531] is a novel antibacterial agent with a unique chemical structure and mode of action apart from other antibiotic agents. Produced by fermentation using the organism _Pseudomonas fluorescens_, mupirocin is a naturally-occurring antibiotic that displays a broad-specturm activity against many gram-positive bacteria and certain gram-negative bacteria _in vitro_.[L10580] It primarily works by inhibiting bacterial protein synthesis. Due to its unique mode of action of inhibiting the activity of bacterial isoleucyl-tRNA synthetase, mupirocin does not demonstrate cross-resistance with other classes of antimicrobial agents, giving it a therapeutic advantage.[L10580] It is available in topical formulations only due to extensive systemic metabolism[A178531] and is used in the treatment of impetigo caused by _Staphylococcus aureus_ and _Streptococcus pyogenes_ and traumatic skin lesions due to secondary skin infections caused by _S. aureus_ and _S. pyogenes_. There is also some clinical evidence that suggests the potential role of mupirocin in eradicating nasal carriage of Staphylococci when administered intranasally.[A178531,A178591] Mupirocin is commonly marketed under the brand name Bactroban.
Indications and Usage For the treatment of Staphylococci nasal carriers.
Marketing Status Prescription; Discontinued
ATC Code D06AX09; R01AX06
DrugBank ID DB00410
KEGG ID D01076
MeSH ID D016712
PubChem ID 446596
TTD Drug ID D03JSJ
NDC Product Code 53002-9851; 45802-112; 49999-644; 50436-0025; 50268-568; 43538-310; 0395-8117; 53002-9853; 43538-300; 38779-2545; 21922-029; 68788-9891; 62991-2701; 51672-1312; 68462-564; 68071-4321; 68462-180; 61919-158; 53002-9850; 81033-020; 53002-9852; 63187-151; 63629-8687; 50090-4397; 68071-4789; 50090-1587; 70166-017; 51552-1194; 68462-560; 76420-128; 0168-0352; 63187-261; 51927-0010; 70166-355; 63187-015; 0093-1010; 71589-015; 50090-4349; 62332-624; 51846-1017; 45865-722; 65897-1003; 68254-0010; 70518-2344; 63187-525; 68788-7993; 65897-2003
Synonyms Mupirocin | Pseudomonic Acid A | Mupirocin Calcium | Mupirocin, Sodium Salt | Mupirocin, Lithium Salt | BRL-4910A | BRL 4910A | BRL4910A | Mupirocin, 14C-Labeled | 14C-Labeled Mupirocin | Mupirocin, 14C Labeled | Mupirocin, Calcium Salt (2:1) | Mupirocin, Calcium Salt (2:1), Dihydrate | Pseudomonic Acid | Bactroban
Chemical Information
Molecular Formula C26H44O9
CAS Registry Number 12650-69-0
SMILES CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal pain07.01.05.002--
Anaphylactic shock24.06.02.004; 10.01.07.002--Not Available
Angioedema23.04.01.001; 10.01.05.009--Not Available
Application site pain12.07.01.004; 08.02.01.004--Not Available
Blepharitis23.03.04.012; 06.04.04.001--Not Available
Burning sensation17.02.06.001; 08.01.09.029--Not Available
Cellulitis23.09.01.001; 11.02.01.001--Not Available
Cough22.02.03.001--
Dermatitis23.03.04.002--Not Available
Dermatitis contact23.03.04.004; 12.03.01.040; 10.01.01.003--Not Available
Dermatitis exfoliative23.03.07.001; 10.01.01.004--
Diarrhoea07.02.01.001--
Dizziness17.02.05.003; 02.01.02.004; 24.06.02.007--
Dry mouth07.06.01.002--
Dry skin23.03.03.001--
Dysgeusia17.02.07.003; 07.14.03.001--
Ear pain04.03.01.003--
Eczema23.03.04.006--
Epistaxis24.07.01.005; 22.04.03.001--
Erythema23.03.06.001--Not Available
Furuncle23.09.01.004; 11.02.05.008--Not Available
Gastrointestinal pain07.01.05.005--
Haemoglobin13.01.05.018--Not Available
Headache17.14.01.001--
Hypersensitivity10.01.03.003--
Immune system disorder10.02.01.001--Not Available
Mouth ulceration07.05.06.004--Not Available
Nausea07.01.07.001--
Pain08.01.08.004--
Pharyngitis22.07.03.004; 11.01.13.003; 07.05.07.004--
The 1th Page    1 2    Next   Last    Total 2 Pages